Advancements in nuclear reactor control: New intelligent control system has stronger adaptive capability
Peer-Reviewed Publication
This month, we’re focusing on artificial intelligence (AI), a topic that continues to capture attention everywhere. Here, you’ll find the latest research news, insights, and discoveries shaping how AI is being developed and used across the world.
Updates every hour. Last Updated: 6-Nov-2025 18:11 ET (6-Nov-2025 23:11 GMT/UTC)
Researchers from University of South China, Tsinghua University and Technical University of Munich have developed a whole system uncertainty model and an Intelligent optimized power control system of the space nuclear reactor with faster response, higher control accuracy and stronger adaptability under uncertainty conditions. These research results provide new ideas and solutions for improving the intelligence level and autonomous control capability of advanced nuclear energy systems in complex environments.
Mass General Brigham researchers compared their long-standing diagnostic decision support systems AI tool, DXplain, with modern large language models like ChatGPT and Gemini, finding DXplain performed slightly better. They say their findings, published in JAMA Network Open, suggest that combining DXplain with LLMs could enhance clinical diagnosis and improve both technologies.
Understanding how cities grow is vital for shaping sustainable urban futures—but mapping the true extent of urban expansion remains a formidable technical hurdle.
Insilico Medicine recently unveiled a groundbreaking study developing small molecule inhibitors targeting ENPP1 to effectively modulate the STING pathway and enhance tumor immunity. Published in Nature Communications, the study showcases Insilico's advanced generative AI platform and integrated workflow which identified and validated ENPP1 as a critical immune checkpoint among multiple solid tumors and assisted in developing a highly specific oral ENPP1 inhibitor, ISM5939.
Carnegie Mellon University researchers have developed a new way to help doctors make better, personalized decisions and predict how a disease or treatment might play out in the future. Researchers from CMU’s School of Computer Science developed a new approach to bridge the gap between available data and actionable insight, creating personalized models to help doctors better understand individual patients and improve their prognosis. The researchers published their work in the Proceedings of the National Academy of Sciences. The team introduced contextualized modeling, a family of ultra-personalized machine learning methods, to build individualized gene network models for nearly 8,000 tumors across 25 cancer types simultaneously. These networks helped identify new cancer biology, revealing hidden cancer subtypes and improving survival predictions, especially for rare cancers. This development opens the door to more precise, individualized cancer treatment.
A research paper by scientists at Chinese Academy of Sciences proposed a dual-task learning framework, the “Twin Brother” model, which fuses convolutional neural network (CNN), long short-term memory (LSTM), neural networks (NNs), and the squeezing-elicited attention mechanism to classify the lateral gait stage and estimate the hip angle from electromyography (EMG) signals.
The new research paper, published on May. 1 in the journal Cyborg and Bionic Systems, provide a “Twin Brother” model. The model is a dual-task learning framework designed for simultaneous gait phases recognition for lateral walking and continuous hip angle prediction.
Many policy discussions on AI safety regulation have focused on the need to establish regulatory “guardrails” to protect the public from the risks of AI technology. In a new paper published in the journal Risk Analysis, two experts argue that, instead of imposing guardrails, policymakers should demand “leashes.”